Nona Biosciences and Lycia Therapeutics forge groundbreaking partnership

admin 2024年3月12日

Beginner

science & technology, science & technology - beginner

Pre-reading questions:

I will read each question. Then, please answer them.

講師がそれぞれの質問を読むので答えましょう。

Have partnerships played a role in historical breakthroughs or innovations?
Is it important to continually develop new treatments for various diseases?

Vocabulary:

I will read the words, meanings, and sample sentences. Then, repeat after me.

単語、意味、例文を読みます。講師に続いて音読しましょう。

disease /dih-ZEEZ/

[noun] – a disorder of structure or function in a human, animal, or plant, especially one that produces specific signs or symptoms
The doctor is researching ways to treat the rare disease.

break down /BREYK-doun/

[phrasal verb] – to separate something into smaller parts or to analyze in detail
We need to break down the problem to understand its complexity.

progress /PROG-res/

[noun] – movement toward an improved or more developed state.
The students are making progress in their studies.

firm /furm/

[noun] – a business or a company, particularly one that is involved in a specific type of professional activity
Deltron Technologies, a leading tech firm, specializes in developing advanced AI software solutions for the healthcare industry.

advance /ad-VANS/

[verb] – to move forward or make progress
We need to advance our understanding of science through research.

Article reading:

Please read the whole article. Then, I will check your pronunciation and intonation.

記事を音読しましょう。講師はあなたの発音とイントネーションを確認します。

In a recent development, Nona Biosciences and Lycia Therapeutics have joined forces in collaboration to discover new treatments for challenging diseases. Nona Biosciences, a global biotech company, is partnering with Lycia, known for its lysosomal targeting chimeras (LYTACs) platform. The goal is to find innovative treatments that break down proteins associated with difficult diseases. Through this partnership, Lycia will use Nona’s Harbour Mice® HCAb fully human antibody transgenic mice platform to identify new antibodies for its LYTAC protein degrader treatments. The collaboration aims to accelerate Lycia’s progress in creating these groundbreaking treatments. Dr. Jingsong Wang, Chairman of Nona Biosciences, and Dr. Steve Staben, Chief Scientific Officer of Lycia Therapeutics, are optimistic about the unique capabilities of LYTACs in addressing extracellular disease targets. The overarching goal is to use Nona Biosciences’ technology to discover treatments for patient groups often overlooked in medical research. Nona Biosciences, under HBM Holdings Limited, is a global biotech firm using Harbour Mice® technology to create human monoclonal antibodies for next-gen drugs. Partnering with Lycia Therapeutics, they aim to advance medical research and provide solutions for challenging diseases, emphasizing a commitment to underserved patient populations.

True or False:

Read the sentences and identify if they are true or false based on the article.

文章を読んで、記事に基づいて正誤を答えましょう。

Nona Biosciences and Lycia Therapeutics have collaborated to discover new treatments for common diseases.
Lycia Therapeutics is not known for its lysosomal targeting chimeras (LYTACs) platform.
The goal of the partnership is to find conventional treatments for well-known diseases.
Nona’s Harbour Mice® HCAb platform is not used by Lycia to identify new antibodies.
The collaboration aims to slow down Lycia’s progress in creating groundbreaking treatments.

Fill in the blanks:

Choose the correct word from the table then fill in the blanks.

適切な言葉を選んで空欄を埋めましょう。

disease

break down

progress

firm

advance

The construction project is making steady ______.
Vaccines play a crucial role in preventing the spread of infectious ______.
The technician will ______ the components of the machine for maintenance.
The army was able to ______ and secure the enemy’s territory.
She works for a law ______ in the city center.